Who we are

Across all four sites, our leading neurologists have a neuroimmunological focus and are embedded in strong neuroscientific and immunological communities.  In addition, each site makes its own specific contributions to the initiative.  Leading the research at each of these sites are:

  • Rhine-Main Neuroscience Network: Stefan Bittner, Tobias Bopp, Sergiu Groppa, Helmut Jonuleit, Jonathan Kipnis, Detlef Schuppan,  Albrecht Stroh, Jacky Trotter, Ari Waisman, Nina Wettschureck and Frauke Zipp
  • Munich neuroimmunologists: Klaus Dornmair, Bernhard Hemmer, Reinhard Hohlfeld, Naoto Kawakami, Martin Kerschensteiner, Thomas Korn , Gurumoorthy Krishnamoorthy, Klaus Lehmann-Horn, Edgar Meinl and Mikael Simons
  • Münster Center: Thomas Budde, Catharina Groß, Luisa Klotz, Tanja Kuhlmann, Karin Loser, Sven Meuth, Hans-Christian Pape, Michael Schäfers, Nicholas Schwab, Lydia Sorokin, Heinz Wiendl and Alexander Zarbock
  • Bochum Center: Ralf Gold and Aiden Haghikia

Furthermore, there are three scientists associated to the network:

  • Associates: Gerd Meyer zu Hörste (Münster), Muthuraman Muthuraman (Rhine-Main Neuroscience Network), Anneli Peters (Munich)

News

Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more
Fri, 15/01/2021
Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity
It has long been acknowledged that multiple sclerosis disease risk is associated with reduced sun-exposure, and subsequent low vitamin D levels. The study by Ostkamp et al. now assessed the relationship between measures of sun exposure and MS severity. For this, the researchers analyzed data of around 2,000 patients from the German NationMS- and the […]...more